Figure 3
Metabolite accumulation levels for treatment main effect and treatment x genotype interaction. (A) Hierarchal clustering of metabolites significant for treatment main effect across all genotypes at two different time-points [pre-dawn (PD) and mid-day (MD)]. (B) Venn diagram demonstrating the number of metabolites that are significant for treatment main effect or a 2-way interaction. (C) Mean log2 (fold-change) of metabolite abundance for metabolites that are significant for treatment main effect only.